http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0066001-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J11-00 |
| filingDate | 1981-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1986-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1986-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0066001-B1 |
| titleOfInvention | Pharmaceutical compositions containing androstenes |
| abstract | In a process for the production of pure compounds of the formula I <CHEM> wherein R represents a hydrogen atom or an acetyl group, substantially free of DELTA 3-isomer, a mixture of (5 alpha )-androst-2-en-17-one and (5 alpha )-androst-3-en-17-one is treated with Jones reagent and the pure (5 alpha )-androst-2-en-17-one is isolated from the reaction mixture and further reacted with an alkali metal salt of acetylene and, if desired acetylated. The compounds are useful as pharmaceutical compositions for the treatment of endometriosis; benign breast disease; pituitary-gonadal dysfunction in both sexes, including some forms of infertility and, in animals, the pseudogestational syndrome. |
| priorityDate | 1981-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.